A randomized trial of a formal group program for fatigue in multiple sclerosis
A randomized trial of a formal group program for fatigue in multiple sclerosis
批准号:
8959938
负责人:
Dennis Neil Bourdette
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-10-01 至 2016-09-30
关键词:
AddressAffectAmericanBaltimoreBudgetsCaringClinicClinical Practice GuidelineCommunitiesCommunity HealthConsultCountryDataEducationEffectivenessEnrollmentEnsureEvaluationEvidence based treatmentExerciseFamilyFatigueGoalsGuidelinesHourIndividualInformation ManagementInterventionLanguageLeast-Squares AnalysisLifeLocationMaintenanceMeasuresMinorityModelingMonitorMultiple SclerosisNatureNeuraxisNursesOccupational TherapistOutcome MeasureParticipantPatient Self-ReportPatientsPersonsPharmaceutical PreparationsPhysical activityPilot ProjectsPractice GuidelinesPublishingQuality of lifeRandomizedRandomized Clinical TrialsRecommendationRecruitment ActivityRegression AnalysisReportingResearchResearch PersonnelResearch Project GrantsSF-36Self EfficacySeriesServicesSideSingle-Blind StudySiteSocializationSocietiesStructureSymptomsTestingTimeTrainingTravelVariantVeteransWagesWomanarmbaseclinical practicecostcost effectivediariesdisabling diseasefollow-uphealth administrationhealth related quality of lifeimprovedinnovationmedical schoolsnovelpilot trialprimary outcomeprogramsrandomized trialresponsesocialtreatment trialtrial design
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
The purpose of this research project is to determine if Fatigue: Take Control (FTC), a formal multi-modal program owned and distributed by the National Multiple Sclerosis (MS) Society (NMSS) based on the Fatigue and MS clinical practice guideline, is effective in reducing fatigue in Veterans and others with MS. The specific objectives are: 1) To determine if FTC reduces fatigue in non-depressed ambulatory people with MS at the end of the intervention and at 3, 6 and 12 months after the intervention compared to a general MS group education program on the Modified Fatigue Impact Scale, the primary outcome measure; 2) To determine if FTC increases self-efficacy compared to a general MS group education program in people with MS as measured by the MS Self-Efficacy Scale; 3) To determine if FTC results in subjects reporting a) changes in medication utilization using a self-report medication diary, b) exercise participatio using the self-report Rapid Assessment of Physical Activity and c) quality of life using the SF-36,
and 4) To determine if FTC objectively increases activity participation compared to a general MS group education program using the StepWatch Activity Monitors (SAM). 200 subjects will be enrolled (100 per arm) with 50 at each of four VA sites - Portland, Seattle, Baltimore and Gainesville - for a randomized single blind controlled parallel treatment trial with two arms. It i important to conduct this trial at a minimum of 4 sites to establish that the program is effective t different locations, with different moderators, with an appropriate control intervention to control
for socialization and content, and to ensure rapid enrollment. Subjects will be randomized to participate either in the FTC (includes DVD viewing, discussion, homework and workbooks) or a general MS education program not addressing fatigue (includes discussion and NMSS produced materials). Subjects will attend weekly two-hour group classes for 6 weeks with primary outcome data collected at baseline and one week after completing the classes. At 3 months and 6 months following completion of their respective programs, subjects will undergo repeat evaluations to assess for durability of responses and then will exit the study. Subjects wil be recruited from the VA MS Clinics, the MS Clinics at the affiliated medical schools and the community to assure participation of women and minorities. The SD of difference from baseline MFIS in the pilot study was about 10. This means that groups of about 40 each would provide power of 80% for detecting the clinically meaningful change of 7 units. However, the present study involves comparison of the immediate change from baseline to that several months later, involving more variation with a SD in the pilot study of 16 rather than 10. Power for detecting change of 7 units, using centers of 40 subjects each will provide 80% power of finding significant change at the 5% level with a 2-sided test. We plan to enroll 50 subjects at each site with the goal of retaining at least 40 with reimbursement for time and travel in addition to the quality of the programs. For the primary endpoint analysis, ordinary (i.e. least squares) multiple regression analysis will be employed, stratifying on center, and adjusting for covariates using a binary indicator variable for treatment. The other aspect of the primary aim involves assessing maintenance of any improvement in follow-ups at 3 and 6 months. Changes for individuals will also be used for this: change from baseline for the immediate effect, and change from the end of course for the follow-up effects at 3 and 6 months. We anticipate requiring 48 months for this research project: 12 months to initiate the trial including centralized staff training and purchasig the StepWatch Activity Monitors, 24 months to fully enroll the study, six additional months to complete the trial and six months to complete analysis of the results. The critical staff requiring
salary support will be the Co-Investigator, four Site Coordinators, four consulting MS nurses and four consulting MS physical or occupational therapists (one each at each site). The estimated budget will be $1,160,000 over the four years of the study.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecules Targeting the Mitochondrial Permeability Transition
-
批准号:8435345
-
项目类别:
-
资助金额:$3.06万
-
财政年份:2012
-
负责人:Dennis Neil Bourdette
-
依托单位:
Small Molecules Targeting the Mitochondrial Permeability Transition
-
批准号:8261787
-
项目类别:
-
资助金额:$3.15万
-
财政年份:2012
-
负责人:Dennis Neil Bourdette
-
依托单位:
Lipoic Acid Therapy for Experimental Autoimmune Encephalomyelitis
-
批准号:8195865
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dennis Neil Bourdette
-
依托单位:
Jungers Center New Faculty Recruitment in Genetic Models of Axonal Degeneration
-
批准号:7943930
-
项目类别:
-
资助金额:$65.36万
-
财政年份:2009
-
负责人:Dennis Neil Bourdette
-
依托单位:
Lipoic Acid Therapy for Experimental Autoimmune Encephalomyelitis
-
批准号:8391568
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dennis Neil Bourdette
-
依托单位:
Jungers Center New Faculty Recruitment in Genetic Models of Axonal Degeneration
-
批准号:7861007
-
项目类别:
-
资助金额:$60.95万
-
财政年份:2009
-
负责人:Dennis Neil Bourdette
-
依托单位:
Lipoic Acid Therapy for Experimental Autoimmune Encephalomyelitis
-
批准号:7919383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dennis Neil Bourdette
-
依托单位:
Lipoic Acid Therapy for Experimental Autoimmune Encephalomyelitis
-
批准号:7797254
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:Dennis Neil Bourdette
-
依托单位:
Mitochondrial modulation for neuroprotection in a model of multiple sclerosis
-
批准号:8048966
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2008
-
负责人:Dennis Neil Bourdette
-
依托单位:
Mitochondrial modulation for neuroprotection in a model of multiple sclerosis
-
批准号:8248764
-
项目类别:
-
资助金额:$33.01万
-
财政年份:2008
-
负责人:Dennis Neil Bourdette
-
依托单位:
Mitochondrial modulation for neuroprotection in a model of multiple sclerosis
-
批准号:7588901
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Dennis Neil Bourdette
-
依托单位:
Mitochondrial modulation for neuroprotection in a model of multiple sclerosis
-
批准号:7463230
-
项目类别:
-
资助金额:$33.69万
-
财政年份:2008
-
负责人:Dennis Neil Bourdette
-
依托单位:
Mitochondrial modulation for neuroprotection in a model of multiple sclerosis
-
批准号:7798016
-
项目类别:
-
资助金额:$33.35万
-
财政年份:2008
-
负责人:Dennis Neil Bourdette
-
依托单位:
Study to evaluate the role of an oral antioxidant, alpha lipoic acid in MS
-
批准号:6981119
-
项目类别:
-
资助金额:$8.8万
-
财政年份:2003
-
负责人:Dennis Neil Bourdette
-
依托单位:
Natural Antioxidant in the Treatment of MS
-
批准号:6210970
-
项目类别:
-
资助金额:$21.35万
-
财政年份:1999
-
负责人:Dennis Neil Bourdette
-
依托单位:
海外基金